Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Morphine antibody

The Mouse Monoclonal anti-Morphine antibody (Clone BDI263) (ABIN263877) specifically detects Morphine in LF and EIA.
Catalog No. ABIN263877
$846.00
Plus shipping costs $50.00
1 mg
Shipping to: United States
Delivery in 1 to 2 Business Days

Quick Overview for Morphine antibody (ABIN263877)

Target

Morphine

Host

  • 30
  • 5
  • 2
  • 1
Mouse

Clonality

  • 30
  • 8
Monoclonal

Conjugate

  • 19
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Morphine antibody is un-conjugated

Application

  • 20
  • 10
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Lateral Flow (LF), Enzyme Immunoassay (EIA)

Clone

BDI263
  • Purification

    Protein A chromatography

    Immunogen

    Morphine-BTG

    Isotype

    IgG1
  • Application Notes

    Tested in a rapid test (lateral flow) format.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Concentration

    2.58mg/mL

    Buffer

    0.15 M PBS, pH 7.4 containing 0,09 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
    Shelf life: one year from despatch.

    Expiry Date

    12 months
  • Target

    Morphine

    Target Type

    Chemical

    Background

    Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.
You are here:
Chat with us!